Synchronization of porcine fetal fibroblast cells with topoisomerase-inhibitor hoechst 33342

Anim Reprod Sci. 2001 Apr 30;66(1-2):109-16. doi: 10.1016/s0378-4320(01)00088-4.

Abstract

Proper synchronization of donor nuclei has been shown to have a major influence on the developmental potential of nuclear transfer embryos. In the present study, a protocol was established to synchronize porcine fetal fibroblasts in the G2 stage of the cell cycle. Cell cycle analyses were performed by flow cytometry. Cells were pre-synchronized by serum deprivation or aphidicoline-treatment; then incubated in medium containing 0.1 microg/ml Hoechst 33342 (H342). The fluorochrome H342 has been shown to be a topoisomerase-inhibitor that can inhibit progression through the cell cycle. There was no significant difference in the percentage of fibroblasts in G2/M whether cells were pre-synchronized in medium supplemented with 0.1% serum for 48h or 0.5% serum for 6 days. Compared with controls, pre-synchronization in early S-phase before incubation in H342 increased the proportion of G2/M fibroblasts; also an increase from 0 and 6 versus 12h culture in complete medium before incubation in H342 resulted in an increased percentage of cells in G2/M at the end of the synchronization period (9.3 and 13.1% versus 33.7%; P<0.001). Neither an increase in the concentration of H342 (0.1-1.0 microg/ml) nor a longer exposure time (12h versus 18h versus 24h) increased the proportion of G2/M fibroblasts. The protocol established in this study arrested porcine fibroblasts reversibly in the G2/M-stage and is therefore suitable to provide synchronized cells for nuclear transfer experiments.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzimidazoles / pharmacology*
  • Cell Cycle / drug effects*
  • Enzyme Inhibitors / pharmacology*
  • Fetus / cytology*
  • Fibroblasts / cytology*
  • G2 Phase
  • Gestational Age
  • Mitosis
  • Nuclear Transfer Techniques
  • Swine / embryology*
  • Topoisomerase I Inhibitors*

Substances

  • Benzimidazoles
  • Enzyme Inhibitors
  • Topoisomerase I Inhibitors
  • bisbenzimide ethoxide trihydrochloride